PharmaShots Connects Brands & Decision-Makers with Custom Media Solutions PharmaShots Provides Curated News & Insights for the Biopharma & Healthcare Industry PharmaShots is Empowering Decision Makers with Actionable Insights Amplify Your Brand with PharmaShots’ Expert Content Creation & Marketing Solutions PharmaShots Enables Brands to Strategically Connect with Their Target Audiences Deliver Your News to the Right Audience with PharmaShots Newswire SPOTLIGHT INTERVIEW SPOTLIGHTCXO Talks: Tim O’Connell from Emtelligent in a Striking Conversation with PharmaShots SPOTLIGHTCXO Talks: Colin Banas from DrFirst in an Illuminating Conversation with PharmaShots SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Michael Bierl SPOTLIGHTReuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Hector De La Riva SPOTLIGHTCXO Talks: Ali Jannati from Linus Health in a Stimulating Dialogue Exchange with PharmaShots SPOTLIGHTReuters Pharma 2025: Pre-Conference Talks Featuring Mike Ryan EXCLUSIVE INTERVIEW EXCLUSIVEExclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind EXCLUSIVEExclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots EXCLUSIVEExclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEAdvancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEDecoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots EXCLUSIVEAdvancing Urothelial Carcinoma Care: Ahsan Arozullah from Astellas Pharma in an Exclusive Interview with PharmaShots EXCLUSIVEExclusive: David Esposito in an Illuminating Discussion with PharmaShots EXCLUSIVEExclusive: GeoVax’s CEO David A. Dodd in an Engaging Conversation with PharmaShots LATEST NEWSStay up-to-date Sobi Reports the US FDA’s Approval of Doptelet (Avatrombopag) to Treat Pediatric Immune Thrombocytopenia 5 hours ago Memo Therapeutics Reports P-II (SAFE KIDNEY II) Trial Data on Potravitug to Treat BKPyV Infection in Kidney Transplant Recipients 6 hours ago Biogen’s Zurzuvae Receives the CHMP’s Positive Opinion to Treat Severe Postpartum Depression 7 hours ago Gilead Reports the CHMP’s Positive Opinion on Lenacapavir for Pre-Exposure Prophylaxis (PrEP) to Prevent HIV in Individuals at Risk 9 hours ago GSK Enters a ~$12.5B Deal with Hengrui Pharma to Develop up to 12 Novel Therapeutics Across Various Indications 10 hours ago KalVista Reports the CHMP’s Positive Opinion on Sebetralstat for Treating Hereditary Angioedema 11 hours ago Read More Your Daily Dose of Biopharma News & Insights Delivered to Your Inbox. Join the PharmaShots Family of 20000+ subscribers Subscribe Now Youtube VideosStay up-to-dateMore Posts
Sobi Reports the US FDA’s Approval of Doptelet (Avatrombopag) to Treat Pediatric Immune Thrombocytopenia 5 hours ago
Memo Therapeutics Reports P-II (SAFE KIDNEY II) Trial Data on Potravitug to Treat BKPyV Infection in Kidney Transplant Recipients 6 hours ago
Biogen’s Zurzuvae Receives the CHMP’s Positive Opinion to Treat Severe Postpartum Depression 7 hours ago
Gilead Reports the CHMP’s Positive Opinion on Lenacapavir for Pre-Exposure Prophylaxis (PrEP) to Prevent HIV in Individuals at Risk 9 hours ago
GSK Enters a ~$12.5B Deal with Hengrui Pharma to Develop up to 12 Novel Therapeutics Across Various Indications 10 hours ago
KalVista Reports the CHMP’s Positive Opinion on Sebetralstat for Treating Hereditary Angioedema 11 hours ago
